Cortical Excitability and Role of rTMS in Cannabis Use Disorder

NCT ID: NCT04106336

Last Updated: 2019-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

EARLY_PHASE1

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-01

Study Completion Date

2020-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cannabis Use Disorder, Moderate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

non cannabis addict

30 non cannabis addict will be control group

Group Type NO_INTERVENTION

No interventions assigned to this group

cannabis addict

30 cannabis addict will undergo rTMS

Group Type ACTIVE_COMPARATOR

rTMS

Intervention Type DEVICE

Repetitive transcranial magnetic stimulation (rTMS) will be done for cannabis addict

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rTMS

Repetitive transcranial magnetic stimulation (rTMS) will be done for cannabis addict

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18to 50 years of age
* cannabis use disorder according to DSM 5 definition
* clear consent to participate in study

Exclusion Criteria

* cardiac peacemaker
* metal implant in the head as participate will be applied to magnetic field of TMS
* current intake of any medication affect cognition (as anti psychotic and anti epileptic)
* current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .
* age younger than 18 and older than 50 years
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asmaa Omar Radwan Helal

Asmaa Omar Radwan Helal

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

rTMS in cannabis use disorder

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

rTMS for Stimulant Use Disorders
NCT04907357 COMPLETED NA
rTMS in Older Adults With MCI and AUD
NCT05896332 ACTIVE_NOT_RECRUITING PHASE1